17-α hydroxyprogesterone caproate (17-OHPC) could alter the immune response and inflammation, specifically affecting risk of preterm labor preeclampsia. However, exact inflammatory effects 17-OHPC remain hard to be identified. The current literature on is limited more research needed identify these mechanistic pathways. Further, coronavirus disease 2019 (COVID-19) infection in pregnancy involve...